0001415889-24-022784.txt : 20240904
0001415889-24-022784.hdr.sgml : 20240904
20240904163414
ACCESSION NUMBER: 0001415889-24-022784
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240903
FILED AS OF DATE: 20240904
DATE AS OF CHANGE: 20240904
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EDGEMOND JAMES
CENTRAL INDEX KEY: 0001636178
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 241278057
MAIL ADDRESS:
STREET 1: 1040 SPRING STREET
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1000 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4-09042024_040904.xml
X0508
4
2024-09-03
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001636178
EDGEMOND JAMES
C/O UNITED THERAPEUTICS CORPORATION
1000 SPRING STREET
SILVER SPRING
MD
20910
false
true
false
false
CFO AND TREASURER
1
Common Stock
2024-09-03
4
M
0
3266
120.26
A
5881
D
Common Stock
2024-09-03
4
S
0
3266
362.37
D
2615
D
Common Stock
2024-09-03
4
M
0
3400
117.76
A
6015
D
Common Stock
2024-09-03
4
S
0
3400
362.37
D
2615
D
Common Stock
2024-09-03
4
M
0
816
120.26
A
3431
D
Common Stock
2024-09-03
4
S
0
550
362.37
D
2881
D
Common Stock
2024-09-03
4
M
0
850
117.76
A
3731
D
Common Stock
2024-09-03
4
S
0
569
362.37
D
3162
D
Stock Options
120.26
2024-09-03
4
M
0
3266
0
D
2017-03-15
2026-03-15
Common Stock
3266
37570
D
Stock Options
117.76
2024-09-03
4
M
0
3400
0
D
2021-03-15
2027-03-15
Common Stock
3400
150600
D
Stock Options
120.26
2024-09-03
4
M
0
816
0
D
2017-03-15
2026-03-15
Common Stock
816
36754
D
Stock Options
117.76
2024-09-03
4
M
0
850
0
D
2021-03-15
2027-03-15
Common Stock
850
149750
D
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on May 17, 2024.
This option exercise was a "sell-to-cover" transaction whereby the reporting person exercised 816 stock options, sold 550 of the resulting shares of common stock, and held the remaining 266 shares of common stock.
This option exercise was a "sell-to-cover" transaction whereby the reporting person exercised 850 stock options, sold 569 of the resulting shares of common stock, and held the remaining 281 shares of common stock.
/s/ John S. Hess, Jr. under Power of Attorney
2024-09-04